Medical e-commerce is about to erupt

The year 2012 was the first year of the development of Chinese medicine B2C. After several years of prolonged life, the medical e-commerce finally broke out in the “small universe” and reached a market scale of 1.665 billion yuan.

The situation of e-commerce and traditional retail can be regarded as twofold. In the case of traditional retail downturn, e-commerce has been advancing rapidly: Alibaba Group announced that as of November 30, 2012, the transaction volume of Taobao and Tmall will be held in this year. A breakthrough of 1 trillion yuan, equivalent to the sum of the transaction volume of eBay (75 billion U.S. dollars) and Amazon (90 billion U.S. dollars) this year, and 2% of the GDP of China in 2011. In 2011, China had only 18 provinces with GDP exceeding RMB 1 trillion.

Ma Yun said: 1 trillion yuan has only just begun. We are entering an era of 10 trillion yuan. In the Internet environment, the essence of e-commerce is by no means a “virtual economy” that many people have previously understood. In fact, e-commerce is a real new economy. It is a new economic model that integrates information technology on the Internet and the traditional real economy.

After 3 years, "Suning vs. JD.com" will be staged.
At the 2012 CCTV Annual Economic Figures Awards Evening, Ma Yun should have placed a bet on Wang Jianlin, chairman of Wanda Group: In 2020, if the e-commerce business accounted for 50% of the retail market in China, Wang gave the horse a billion, if not, Ma Give the king a billion.

By 2015, a billion-dollar online pharmacy will be available, and the traditional drugstore's “first-person brother” should be a mass of 5 billion. At that time, it is entirely possible to stand in court! When Jingdong challenges Suning, his body has only Suning’s. One-fifth (20 billion vs 100 billion). At that time, the chain pharmacies face a situation of large-scale losses, and will stage a drama of “chain pharmacy winter vs. online pharmacy spring”. Perhaps by that time, chain pharmacy bigwigs would have to make a transition in 2012 like Suning.

Ma Yun said last year: "Now the retail industry hates me, but it does not even have the strength to fight back, because I will not give you the opportunity to fight back, when you think of a counterattack."

2012 medical B2C transcript

In 2012, the scale of China's pharmaceutical B2C transaction began to show explosive growth, and with the increase in the number of pharmaceutical B2C companies, it further promoted the development of the pharmaceutical retail online shopping market. According to the latest statistics from the China Online Drugstore Council, the total annual B2C medical scale in China reached 1.665 billion in 2012, which was only 400 million yuan in 2011.

In 2012, the platform-type trading scale of the medical B2C was 750 million for the whole year, accounting for 45% of the transaction volume in the B2C market. The transaction scale of the autonomous medicine B2C was 915 million yuan for the whole year, accounting for 55% of the total, up from the same period in 2011. 400 million yuan, an increase of 128%.

The main factors driving the growth of the Chinese pharmaceutical B2C market trading volume come from three sources:

1. The involvement of Tmall and Jingdong Mall's large-scale platform e-commerce business has promoted the growth of the B2C's transaction scale and user demand;

2. The scale of online shopping users has grown steadily, the scope of purchases has gradually expanded, and users’ trust in online drug purchases has also increased. Per-capita consumer purchase support has continued to increase;

3. The increase in market participants has expanded the investment in the pharmaceutical B2C market and further expanded the market.

In terms of operational data, the gross margin of the online pharmacy official website (autonomous B2C) is 20% to 25%, the average customer unit price is 300 yuan, and the website conversion rate is 1.5% to 2%. The gross profit rate of platform B2C is 15%, the average customer unit price is 152 yuan, and the website conversion rate is 8%.

However, the entire industry is still in its early stages of development. Although there are more than 40 online pharmacies stationed in Tmall, 37 of the 68 online pharmacies (up to the end of December 2012) have detected no traffic, and only 10 have daily independent IPs above 10,000. . This is equivalent to "most of the online stores are located, but not yet opened."

Therefore, with conservative estimates, the eruption of pharmaceutical e-commerce should be in 2014 and 2015, and by 2015, the market size will reach 15 billion.

Just as Lynx's vice president Ma Xuejun said, “There are millions of sellers on Taobao, and Tmall has more than 60,000 sellers on the B2C platform. However, there are only 40 sellers registered in Tmall Medicine Hall, and they have obtained national The total number of approved online pharmacies is only 68. Such a large market has only so few merchants participating, indicating that the e-commerce competition in the pharmaceutical industry is far from being formed, whether it is from the market competition environment or from the perspective of growth. The opportunity is too great."